TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G1- to S-phase transition

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 10, 2008, Pages 733-738

  Wang, Yi Dong ^a   Bian, Guo Hui ^a   Lv, Xiao Yan ^a   Zheng, Rong ^a   Sun, Huan ^a   Zhang, Zheng ^a   Chen, Ye ^a   Li, Qin Wei ^a   Xiao, Yan ^a   Yang, Qiu Tan ^a   Ai, Jian Zhong ^a   Wei, Yu Quan ^a   Zhou, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cell proliferation; Cyclin D1; ERK1 2 signaling pathway; G1 to S phase transition; TC1 (C8orf4)

Indexed keywords

EID: 55249112997     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.10.733     Document Type: Article

References (28)

1. Chua, E. L., Young, L., Wu, W. M., Turtle, J. R. and Dong, Q. (2000) Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics 69, 342-347.
2. Jung, Y., Bang, S., Choi, K., Kim, E., Kim, Y., Kim, J., Park, J., Koo, H., Moon, R. T., Song, K. and Lee, I. (2006) TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby. Cancer Res. 66, 723-728.
3. Sunde, M., McGrath, K. C., Young, L., Matthews, J. M., Chua, E. L., Mackay, J. P. and Death, A. K. (2004) TC-1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer. Cancer Res. 64, 2766-2773.
4. Yang, Z. Q., Moffa, A. B., Haddad, R., Streicher, K. L. and Ethier, S. P. (2007) Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int. J. Cancer 121, 1265-1273.
5. Friedman, J. B., Brunschwig, E. B., Platzer, P., Wilson, K. and Markowitz, S. D. (2004) C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer. Int. J. Cancer 111, 72-75.
6. Kim, B., Koo, H., Yang, S., Bang, S., Jung, Y., Kim, Y., Kim, J., Park, J., Moon, R. T., Song, K. and Lee, I. (2006) TC1 (C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer. Clin. Cancer Res. 12, 3541-3548.
7. Kim, Y., Kim, J., Park, J., Bang, S., Jung, Y., Choe, J., Song, K. and Lee, I. (2006) TC1(C8orf4) is upregulated by IL-1beta/TNF-alpha and enhances proliferation of human follicular dendritic cells. FEBS Lett. 580, 3519-3524.
8. Morin, P. J. and Weeraratna, A. T. (2003) Wnt signaling in human cancer. Cancer Treat Res. 115, 169-187.
9. Moon, R. T., Bowerman, B., Boutros, M. and Perrimon, N. (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296, 1644-1646.
10. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A. and Henderson, B. E. (1990) Increased cell division as a cause of human cancer. Cancer Res. 50, 7415-7421.
11. Sherr, C. J. (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer. Res. 60, 3689-3695.
12. Johnson, D. G. and Walker, C. L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
13. Meloche, S. and Pouyssegur, J. (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227-3239.
14. Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A. and Pestell, R. G. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597.
15. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R. and Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616.
16. Diehl, J. A. (2002) Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1, 226-231.
17. Chen, R. H., Sarnecki, C. and Blenis, J. (1992) Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell Biol. 12, 915-927.
18. Lenormand, P., Sardet, C., Pages, G., L'Allemain, G., Brunet, A. and Pouyssegur, J. (1993) Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122, 1079-1088.
19. Yamamoto, T., Ebisuya, M., Ashida, F., Okamoto, K., Yonehara, S. and Nishida, E. (2006) Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16, 1171-1182.
20. Malumbres, M. and Barbacid, M. (2001) To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222-231.
21. Roovers, K., Davey, G., Zhu, X., Bottazzi, M. E. and Assoian, R. K. (1999) Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol. Biol. Cell 10, 3197-3204.
22. Kerkhoff, E. and Rapp, U. R. (1998) Cell cycle targets of Ras/Raf signalling. Oncogene 17, 1457-1462.
23. Roovers, K. and Assoian, R. K. (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22, 818-826.
24. Fu, M., Wang, C., Li, Z., Sakamaki, T. and Pestell, R. G. (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145, 5439-5447.
25. Imanishi, Y., Hosokawa, Y., Yoshimoto, K., Schipani, E., Mallya, S., Papanikolaou, A., Kifor, O., Tokura, T., Sablosky, M., Ledgard, F., Gronowicz, G., Wang, T. C., Schmidt, E. V., Hall, C., Brown, E. M., Bronson, R. and Arnold, A. (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J. Clin. Invest 107, 1093-1102.
26. Lai, Y., Xin, D., Bai, J., Mao, Z. and Na, Y. (2007) The important anti-apoptotic role and its regulation mechanism of PTTG1 in UV-induced apoptosis. J. Biochem. Mol. Biol. 40, 966-972.
27. Zhang, K., Ye, C., Zhou, Q., Zheng, R., Lv, X., Chen, Y., Hu, Z., Guo, H., Zhang, Z., Wang, Y., Tan, R. and Liu, Y. (2007) PKD1 inhibits cancer cells migration and invasion via Wnt signaling pathway in vitro. Cell Biochem. Funct. 25, 767-774.
28. Upadhyaya, K. R., Radha, K. S. and Madhyastha, H. K. (2007) Cell cycle regulation and induction of apoptosis by beta-carotene in U937 and HL-60 leukemia cells. J. Biochem. Mol. Biol. 40, 1009-1015.